J&J | JNJ - Ebitda


J&J reported $8.27B in EBITDA for its fiscal quarter ending in March of 2026.





Ebitda Change Date
AbbVie USD 3.69B 1.68B Mar/2026
Abbott USD 2.43B 844M Mar/2026
Amgen USD 3.86B 1.28B Mar/2026
AstraZeneca USD 5.16B 510M Jun/2026
Baxter International USD 309M 756M Mar/2026
Bayer EUR 2.14B 2.31B Jun/2026
Becton, Dickinson and Co. USD 1.71B 1B Jun/2026
Biogen USD 649.7M 76.5M Mar/2026
Boston Scientific USD 1.63B 27M Jun/2026
Bristol-Myers Squibb USD 4.24B 1.37B Mar/2026
CONMED USD 78.12M 21.73M Jun/2026
Cooper Companies USD 67.9M 255.5M Mar/2026
Dexcom USD 364.5M 57.7M Mar/2026
Edwards Lifesciences USD 555.6M 485.5M Mar/2026
Eli Lilly USD 10.29B 1.86B Mar/2026
Gilead Sciences USD 3.51B 489M Mar/2026
GlaxoSmithKline GBP 3.51B 734M Jun/2026
Globus Medical USD 279.84M 48.01M Jun/2026
Insulet USD 199.8M 18.1M Jun/2026
Integra LifeSciences USD 78.41M 2.23M Jun/2026
Intuitive Surgical USD 1.06B 29.9M Mar/2026
J&J USD 8.27B 1.08B Mar/2026
Medtronic USD 2.63B 174M Jun/2026
Merck USD -1.54B 7.84B Mar/2026
Merit Medical Systems USD 104.39M 10.97M Jun/2026
Novartis USD 6.48B 1.19B Jun/2026
Pfizer USD 6.01B 18M Jun/2026
Regeneron Pharmaceuticals USD 1.66B 695.2M Jun/2026
Roche Holding CHF 13.43B 744M Jun/2026
Sanofi EUR 3.69B 375M Jun/2026
Stryker USD 1.93B 357M Jun/2026
Tandem Diabetes Care USD 6.42M 3.69M Jun/2026
Teva Pharmaceutical Industries USD 474M 581M Jun/2026
Vertex Pharmaceuticals USD 1.33B 130.5M Jun/2026
Zimmer Biomet Holdings USD 830.5M 190.4M Jun/2026
Zoetis USD 939M 0 Mar/2026